Completed NA INTERVENTIONAL 2-arm NCT01982578

Genistein as a Possible Treatment for Alzheimer's Disease. (GENIAL)

Effect of Activation of the Receptor PPARg/RXR as a Possible Treatment for Alzheimer's Disease. Role of Genistein.

Sponsor: Fundación para la Investigación del Hospital Clínico de Valencia

Updated 8 times since 2017 Last updated: Sep 9, 2021 Started: Sep 1, 2017 Primary completion: Sep 30, 2020 Completion: Dec 31, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Alzheimer's Disease, this trial is completed. The trial is conducted by Fundación para la Investigación del Hospital Clínico de Valencia and has accumulated 8 data snapshots since 2017. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Oct 2021 — Jul 2024 [monthly]

Completed NA

Status: Recruiting → Completed
Jan 2021 — Oct 2021 [monthly]

Recruiting NA
Aug 2019 — Jan 2021 [monthly]

Recruiting NA

Status: Unknown Status → Recruiting

▶ Show 3 earlier versions

Oct 2018 — Aug 2019 [monthly]

Unknown Status NA

Status: Recruiting → Unknown Status
Jun 2018 — Oct 2018 [monthly]

Recruiting NA
Jan 2017 — Jun 2018 [monthly]

Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Fundación para la Investigación del Hospital Clínico de Valencia
University of Valencia

Data source: Fundación para la Investigación del Hospital Clínico de Valencia

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Valencia, Spain